- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02314858
Tailored Treatment to Enhance Risk Perception in Sleep Apnea
Tailored Treatment to Enhance Risk Perception in Sleep Apnea.
Obstructive Sleep Apnea (OSA) is seen in approximately 6% of Americans. It is a serious medical condition with significant medical and psychological consequences, including diabetes, hypertension, and cardiovascular disease. The treatment of choice for OSA is Positive Airway Pressure therapy (PAP). PAP supplies positive pressure to the upper airway creating a "pneumatic splint" to keep the airway open during sleep. Adherence to PAP is notoriously low, with as few as 50% reaching minimal guidelines for adherence. One comprehensive review of adherence research found that adherence to PAP was less than that for any other medical disorder. The problem of adherence is significant not only because of the medical consequences that can ensue, but also because third party payers have begun to refuse to pay for PAP therapy when adherence is less than optimal, even in the face of clinical improvement. This is a critical time to address this problem.
This research study is designed to identify methods that may help people respond to PAP, the most common therapy for OSA. Identifying these methods may be an important way to better care for patients with obstructive sleep apnea. With this research, the investigators hope to find ways to help people have a better response to treatment and a better quality of life.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80206
- National Jewish Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Polysomnography (PSG) confirmed diagnosis of Obstructive Sleep Apnea (OSA)
- choice of PAP as preferred treatment
- judged by sleep physicians to be responders to PAP
- participants will be considered responders to PAP if they have an AHI of less than 5, do not snore, and have an arousal index of less than 10 when titrated to the proper pressure of PAP
Exclusion Criteria:
- Apnea-Hypopnea Index (AHI) < 15 on the diagnostic PSG and no daytime functional symptoms or associated cardiovascular disease
- a sleep disorder other than OSA that causes arousals from sleep (e.g., periodic limb movements, restless legs syndrome, insomnia)
- a current substance abuse problem
- a serious sleep-disruptive medical condition (e.g., end stage renal failure, severe Chronic Obstructive Pulmonary Disease (COPD), severe asthma)
- significant global cognitive impairment
- history of or current diagnosis of psychosis, bipolar disorder, or borderline, schizotypal or antisocial personality disorder, and uncontrolled depression or suicidal ideation
- change in antidepressant medications over the past 3 months
- women pregnant women, breast feeding, or planning on becoming pregnant
- currently enrolled in another research study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Brief Personalized Video (BPV)
Our BPV intervention focuses on augmenting risk perception and reducing optimistic bias by showing the patient a dramatic video of his/her own apnea (which shows them struggle to breathe), as well as by explaining the physiological processes involved in an apneic event.
Specific apneic events are highlighted and associated decreases in blood oxygen levels are demonstrated via oxygen saturation recording superimposed on the video.
This group will receive educational information about OSA, its consequences and the need for treatment.
|
The BPV group will view a portion of their own sleep study that took place during their overnight sleep study.
Other Names:
|
ACTIVE_COMPARATOR: Non-Personalized Video (NPV)
NPV will include a video of someone having apnea, but it will not be personalized.
This group will receive educational information about OSA, its consequences and the need for treatment.
|
The NPV group will see a stock video of someone with OSA.
Other Names:
|
PLACEBO_COMPARATOR: Treatment As Usual (TAU)
The TAU group will receive no special treatment from study interventionist team and will not view a video.
|
The TAU group will not watch a video.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Treatment Adherence
Time Frame: 90 days
|
Treatment adherence as measured directly from the participant's PAP device.
Adherence is monitored objectively as time at prescribed pressure and daily measures of adherence are transmitted remotely to the study site nightly using a wireless modem.
There are several specific adherence measures that will be available from the PAP units.
These include the average hours of use per night across all nights, the average hours of use on nights PAP is actually used, and the percentage of nights PAP is used across all nights.
|
90 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mark Aloia, PhD, National Jewish Health
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2809
- R01HL120693 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Sleep Apnea (OSA)
-
Brigham and Women's HospitalCompletedObstructive Sleep Apnea (OSA)United States
-
Hospital for Special Surgery, New YorkCompletedObstructive Sleep Apnea (OSA)
-
Mayo ClinicCompletedObstructive Sleep Apnea (OSA)United States
-
ResMedCompletedObstructive Sleep Apnea (OSA)United States, Australia
-
Mauro ManconiCompletedObstructive Sleep Apnea Syndrome | Sleep Apnea, Obstructive | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | OSAHSwitzerland
-
ApnimedCompletedOSA - Obstructive Sleep ApneaUnited States
-
Tufts Medical CenterRespiratory Motion, Inc.Active, not recruitingObstructive Sleep Apnea (OSA)United States
-
Weill Medical College of Cornell UniversityTerminatedObstructive Sleep Apnea (OSA)United States
-
Weill Medical College of Cornell UniversityCornell UniversityWithdrawn
Clinical Trials on Brief Personalized Video (BPV)
-
Exact Sciences CorporationMayo Clinic; University of Utah; American Cancer Society, Inc.; F!ght Colorectal...Recruiting
-
New York State Psychiatric InstituteNot yet recruitingDepression | Mental Health Disorder | Adolescent Behavior | Stigma, SocialUnited States
-
Wolfson Medical CenterNot yet recruitingInduction of Labor Affected Fetus / Newborn
-
University of MichiganCompletedPregnancy | Weight GainUnited States
-
New York State Psychiatric InstituteNot yet recruitingDepression | Mental Health Disorder | Stigma, SocialUnited States
-
GistMed Ltd.UnknownPleural Effusion, Malignant | Pleural Effusion | Pleural Pleurisy EffusionIsrael
-
New York State Psychiatric InstituteColumbia UniversityNot yet recruitingDepression | Stigma, Social | Adolescent - Emotional Problem | Help-Seeking BehaviorUnited States
-
University of California, Los AngelesUnknownCovid-19 | Critical Illness | Health Behavior | Health Care Utilization | Attitude of Health Personnel | Attitude to HealthUnited States
-
The University of Hong KongRecruitingCancer | LungHong Kong
-
Valleywise HealthAmerican Heart Association; University of ArizonaCompleted